# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Raymond James analyst Jayson Bedford maintains Boston Scientific (NYSE:BSX) with a Strong Buy and raises the price target fr...
Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $90 to $92.
Barclays analyst Matt Miksic maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target from $78 t...